Novel medical technologies and drug platforms such as mRNA and lipid nanoparticles are revolutionizing healthcare, with applications in such critical areas as cancer treatment, rare diseases, and novel vaccines. We are honored to have join us today three recipients of the international Tang Prize in Biopharmaceutical Science, awarded for their role in developing mRNA vaccines, to examine what the future holds for these exciting new technologies. Join us for a thought-provoking and informative session on the cutting edge of drug development technologies.
09:00 – 10:30 | Session 1 (Plenary) – Global Biotech Development |
---|---|
09:00 – 09:25 |
Conference Opening Yi-Juang Chern, Deputy Minister, National Science and Technology Council |
09:25 – 09:45 | Session Chair Chung-Hsiun Wu, Chairman, Taiwan Bio Industry Organization Impact of Key Policy Changing on Biopharma Industry |
09:45 – 10:00 | Design of Lipid Nanoparticles that Enable Gene Therapies
Pieter Cullis, Professor, University of British Columbia, 2022 Tang Prize Laureate |
10:00 – 10:15 | Developing mRNA for Therapy |
10:15 – 10:30 | 2023 Health Trends
Sam Wilson, SVP and Head of APAC, Deployment Solutions, Syneos Health |
10:30 – 10:40 | Break |